狂犬病診斷市場、機會、成長動力、產業趨勢分析與預測，2024-2032

在對可靠、準確的診斷方法的需求不斷成長的推動下，全球狂犬病診斷市場預計在 2024 年至 2032 年間以 4.7% 的複合年成長率擴張。狂犬病是一種致命的病毒性疾病，繼續對公共衛生構成重大挑戰，特別是在低收入和中等收入國家。世界衛生組織 (WHO) 報告稱，狂犬病每年導致數萬人死亡，其中大多數發生在亞洲和非洲。隨著人們越來越關注早期和準確的疾病檢測，先進的狂犬病診斷方法的採用將顯著增加，從而支持市場成長。

整個狂犬病診斷產業根據測試類型、技術、樣本類型、最終用途和地區進行分類。

到 2032 年，色譜細分市場將佔據狂犬病診斷市場的重要佔有率。該技術能夠分離和分析複雜的生物樣品，使其成為狂犬病檢測的首選。狂犬病在各個地區的盛行率不斷上升，加上對先進診斷技術的需求，正在推動色譜法在狂犬病診斷中的採用。此外，色譜技術的不斷進步和創新將提高狂犬病檢測的效率和準確性。

診斷實驗室領域將在預測期內大幅成長。診斷實驗室在狂犬病的早期檢測和管理中發揮著至關重要的作用，提供專業的檢測服務以確保準確和及時的診斷。狂犬病發病率的上升，特別是在流行地區，導致對診斷服務的需求增加，從而推動了這一領域的成長。此外，不斷擴大的實驗室網路和嚴格的品質控制措施的實施導致狂犬病檢測對診斷實驗室的依賴日益增加。隨著對可靠和標準化診斷服務的需求不斷增加，這種趨勢將持續下去。

在強大的醫療基礎設施、大量研發投資以及公眾對狂犬病預防和控制的高度認知的支持下，歐洲狂犬病診斷市場將在 2024 年至 2032 年實現可觀的成長。該地區完善的診斷設施和強力的監管框架確保了診斷測試的品質和可靠性。此外，旨在根除狂犬病的政府舉措以及歐洲領先診斷公司的存在正在進一步推動創新和市場擴張。因此，歐洲仍將是狂犬病診斷的關鍵地區，為全球市場成長做出重大貢獻。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 動物咬傷案件不斷增加
    • 被忽視的熱帶疾病（NTDS）盛行率不斷上升
    • 診斷技術的進步
    • 政府優惠政策
  • 產業陷阱與挑戰
    • 測試成本高
• 成長潛力分析
• 監管環境
• 技術景觀
• 波特的分析
• PESTEL分析
• 未來市場趨勢

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按測試類型，2021 - 2032 年

• 主要趨勢
• 螢光抗體測試（FAT）
• 免疫組化檢測
• 擴增方法
• 組織學檢查
• 血清學測試

第 6 章：市場估計與預測：按技術分類，2021 - 2032 年

• 主要趨勢
• 酵素連結免疫吸附試驗
• 色譜法
• 聚合酶鍊式反應
• 其他技術

第 7 章：市場估計與預測：按樣本類型，2021 - 2032

• 主要趨勢
• 腦組織
• 唾液
• 腦脊髓液（CSF）
• 血液（血清）
• 其他樣品類型

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 醫院和診所
• 診斷實驗室

第 9 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 10 章：公司簡介

• Abbexa Ltd
• Aviva Systems Biology Corporation
• BIONOTE Co., LTD
• Bio-Rad Laboratories, Inc.
• Creative Diagnostics
• Demeditec Diagnostics GmbH
• Merck KGaA
• MyBioSource, Inc.
• Norgen Biotek Corp.
• Thermo Fisher Scientific Inc.

Global Rabies Diagnostics Market is poised to expand at a 4.7% CAGR between 2024 and 2032, fueled by the increasing demand for reliable and accurate diagnostic methods. Rabies, a fatal viral disease, continues to pose significant public health challenges, particularly in low- and middle-income countries. The World Health Organization (WHO) reports that rabies leads to tens of thousands of fatalities annually, with the majority occurring in Asia and Africa. With the growing focus on early and accurate disease detection, the adoption of advanced rabies diagnostics will rise significantly, supporting market growth.

The overall rabies diagnostics industry is categorized based on Test Type, Technology, Sample Type, End-use, and Region.

The chromatography segment will capture a significant share of the rabies diagnostics market by 2032. Chromatography technology is gaining prominence in rabies diagnostics due to its ability to deliver precise and rapid results. This technology enables the separation and analysis of complex biological samples, making it a preferred choice for rabies detection. The increasing prevalence of rabies in various regions, coupled with the need for advanced diagnostic techniques, is driving the adoption of chromatography in rabies diagnostics. Furthermore, ongoing technological advancements and innovations in chromatography will enhance the efficiency and accuracy of rabies testing.

The diagnostic laboratories segment will grow substantially over the forecast period. Diagnostic laboratories play a crucial role in the early detection and management of rabies, offering specialized testing services that ensure accurate and timely diagnosis. The rising incidence of rabies, particularly in endemic regions, has led to an increased demand for diagnostic services, thereby driving the growth of this segment. Additionally, the expanding laboratory networks and the implementation of stringent quality control measures contribute to the growing reliance on diagnostic laboratories for rabies testing. This trend will continue as the need for reliable and standardized diagnostic services intensifies.

Europe rabies diagnostics market will achieve commendable growth through 2024-2032, supported by a robust healthcare infrastructure, substantial investment in research and development, and a high level of public awareness regarding rabies prevention and control. The region's well-established diagnostic facilities and strong regulatory frameworks ensure the quality and reliability of diagnostic tests. Moreover, government initiatives aimed at eradicating rabies and the presence of leading diagnostic companies in Europe are further driving innovation and market expansion. As a result, Europe will remain a key region for rabies diagnostics, contributing significantly to global market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising cases of animal bites
    • 3.2.1.2 Increasing prevalence of neglected tropical diseases (NTDS)
    • 3.2.1.3 Technological advancements in diagnostics
    • 3.2.1.4 Favorable government policies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of test
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Fluorescent antibody test (FAT)
• 5.3 Immunohistochemical test
• 5.4 Amplification methods
• 5.5 Histologic examination
• 5.6 Serology tests

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 ELISA
• 6.3 Chromatography
• 6.4 PCR
• 6.5 Other techniques

Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Brain tissue
• 7.3 Saliva
• 7.4 Cerebrospinal fluid (CSF)
• 7.5 Blood (Serum)
• 7.6 Other sample types

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Diagnostic laboratories

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Abbexa Ltd
• 10.2 Aviva Systems Biology Corporation
• 10.3 BIONOTE Co., LTD
• 10.4 Bio-Rad Laboratories, Inc.
• 10.5 Creative Diagnostics
• 10.6 Demeditec Diagnostics GmbH
• 10.7 Merck KGaA
• 10.8 MyBioSource, Inc.
• 10.9 Norgen Biotek Corp.
• 10.10 Thermo Fisher Scientific Inc.